logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Managing Breast Cancer Risk 1st Edition Monica Morrow Virgil Craig Jordan

  • SKU: BELL-2267662
Managing Breast Cancer Risk 1st Edition Monica Morrow Virgil Craig Jordan
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Managing Breast Cancer Risk 1st Edition Monica Morrow Virgil Craig Jordan instant download after payment.

Publisher: PMPH-USA
File Extension: PDF
File size: 2.49 MB
Pages: 308
Author: Monica Morrow, Virgil Craig Jordan
ISBN: 155009260X
Language: English
Year: 2003
Edition: 1

Product desciption

Managing Breast Cancer Risk 1st Edition Monica Morrow Virgil Craig Jordan by Monica Morrow, Virgil Craig Jordan 155009260X instant download after payment.

"Managing Breast Cancer Risk" is a single source for information needed by primary care physicians, nurses, gynaecologists, as well as oncologic specialists who deal with women who are concerned about breast cancer. Its purpose is to bring together a multidisciplinary group of experts to address breast cancer risk in a clinically meaningful way. Chapters providing detailed information on individual risk factors are accompanied by a discussion of models, which integrate multiple factors for a more complete assessment of risk. Traditional strategies for risk management, including surveillance and prophylactic surgery, are reviewed, and the data on newer techniques such as ductal lavage and screening with magnetic resonance is presented. The rational for chemoprevention with selective oestrogen receptor modulators (SERMS) is discussed, and the evidence for tamoxifen as a chemopreventative is updated. The potential for chemoprevention with newer SERMS and the aromatase inhibitors is reviewed. Finally, the critical (and often ignored) areas of quality of life and symptom management are addressed.

Related Products